CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Public ClinicalTrials.gov record NCT00056160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-controlled Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized subjects will receive CC-5013 plus high-dose dexamethasone or placebo appearing identical to CC-5013 plus high-dose dexamethasone in 4-week cycles. Each subject will participate in a treatment phase and a follow-up phase.
Study identification
- NCT ID
- NCT00056160
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 353 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 1, 2003 (Actual)
- Primary completion
- Nov 1, 2005 (Actual)
- Completion
- Oct 1, 2008 (Actual)
- Last update posted
- Oct 19, 2017
2003 – 2008
United States locations
- U.S. sites
- 44
- U.S. states
- 24
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Consultants, Inc. | Hoover | Alabama | 35216 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| UCLA School of Medicine | Los Angeles | California | 90095 | — |
| UCSF California | San Francisco | California | 94143 | — |
| Stanford University Medical Center, Division of Hematology | Stanford | California | 94305-5112 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Mayo Clinic- Jacksonville | Jacksonville | Florida | 32224 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Oncology Hematology Consultants | Sarasota | Florida | 34239 | — |
| H Lee Moffitt Cancer Center | Tampa | Florida | 33612-9497 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Medical College of Georgia | Augusta | Georgia | 30912-3125 | — |
| Northwestern University Med Ctr | Chicago | Illinois | 60611-2927 | — |
| Rush Cancer Institute Section of Hematology | Chicago | Illinois | 60612-3824 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Indiana Cancer Research Institute | Indianapolis | Indiana | 46202-5254 | — |
| University of Iowa Hospital Clinic | Iowa City | Iowa | 52242 | — |
| Ocshner Clinical Foundation | New Orleans | Louisiana | 70121 | — |
| Johns Hopkins Medicine Department of Oncology | Baltimore | Maryland | 21231 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| University Of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Mayo Clinic Cancer Center | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine- Sherman Cancer Center | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| St. Vincent's Comprehensive Cancer Center | New York | New York | 10011 | — |
| New York Presbyterian Hospital | New York | New York | 10021 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| MBCCOP Our Lady of Mercy Cancer Center New York Medical College | The Bronx | New York | 10466 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157-1023 | — |
| Cleveland Clinic Myeloma Program | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Kaiser Permanente Northwest Region Center for Health Research | Portland | Oregon | 97227 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Charleston Hematology/Oncology P.A. | Charleston | South Carolina | 29403 | — |
| Medical University of SC | Charleston | South Carolina | 29425 | — |
| South Carolina Oncology Group | West Columbia | South Carolina | 29169 | — |
| Sarah Cannon Cancer Center | Nashville | Tennessee | 37203-1632 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Froedtert Hospital/BMT Medical College of Wisconsin | Milwaukee | Wisconsin | 53226-3522 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00056160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00056160 live on ClinicalTrials.gov.